Here are the top 5 posts this month.

New use of old drug: Sildenafil Citrate (Viagra) improves amniotic fluid index in oligohydramnios.

Sildenafil Citrate (Viagra) improves amniotic fluid index in pregnancies complicated by oligohydramnios according to a new study published ahead of print on March 6,2017 in Journal of Obstetrics and Gynecology. [1]

https://obgynupdated.blogspot.com/2017/03/new-use-of-old-drug-sildenafil-citrate.html

ACOG releases recommendations for management of acute onset, severe hypertension in pregnancy and postpartum period.

It is estimated that ten million women develop preeclampsia each year around the world, with 76,000 deaths due preeclampsia and related hypertensive disorders.  It is also responsible for 50,000 stillbirths and early neonatal deaths in developing nations.

ACOG committee opinion was published online ahead of print in Journal of Obstetrics and Gynecology.

https://obgynupdated.blogspot.com/2017/03/acog-releases-recommendations-for.html

New Single Handed IUD Inserter for LILETTA released easing IUD insertion.

Allergan a leading global pharmaceutical company, and Medicines360, a nonprofit global women's health pharmaceutical company, recently launched the new LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg IUD single-handed inserter (intrauterine device), for use by women to prevent pregnancy for up to three years. The system needs to be replaced after 3 years if continuous protection is desired. 

https://obgynupdated.blogspot.com/2017/03/new-single-handed-iud-inserter-for.html

Ethicon ENSEAL® X1 Large Jaw Tissue Sealer gets FDA approval: Excellent for performing abdominal and vaginal hysterectomies.

Ethicon, today announced the release of its new ENSEAL X1 Large Jaw Tissue Sealer. Designed for use in open surgeries it is an advanced bipolar device that provides less blood loss, less thermal spread, and improved ergonomics compared to as compared to Medtronic’s LigaSure Impact™.

https://obgynupdated.blogspot.com/2017/03/ethicon-enseal-x1-large-jaw-tissue.html

ASCO issues first global resource stratified guidelines for HPV vaccination for the prevention of cervical cancer.

ASCO today issued first guidelines on primary prevention of cervical cancer that can be used by physicians around the globe as it is tailored according to region, social and economic settings and healthcare resources available. The guidelines were published online in Journal of Global Oncology. [1]

The guidelines offer four levels of recommendations: basic, limited, enhanced and maximal based on the country’s healthcare circumstances and were developed by experts from multiple disciplines representing various countries across the globe.

https://obgynupdated.blogspot.com/2017/03/asco-issues-first-global-resource.html